Here's why the NIB (ASX:NHF) share price is pushing higher today

Here's what's happening with the NIB share price today…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The NIB Holdings Limited (ASX: NHF) share price is pushing higher on Thursday morning.

In early trade, the private health insurer's shares are up over 1% to $7.02.

An older woman clasps her hands with joy, smiling at the news on her computer as she sits at her kitchen bench..

Image source: Getty Images

Why is the NIB share price pushing higher?

The catalyst for the rise in the NIB share price this morning has been the release of an update on its premium increases for next year.

According to the release, the company has received approval from the Federal Minister for Health to increase health insurance premiums by an average of 2.66%. This is the company's lowest premium change in two decades.

However, just because the premium increase has been approved, doesn't necessarily mean the company will actually increase them immediately on 1 April.

NIB's Managing Director, Mark Fitzgibbon, revealed that the company is considering deferring premium increases in recognition of the ongoing impact of COVID-19 on its members.

He said: "It's possible the increase could be deferred for likely three months depending upon developments, especially in relation to our claims experience and risk equalisation commitment. We'll provide details on what this looks like for our members in the new year."

Nobody likes premium increases but…

And while Mr Fitzgibbon acknowledged that consumers never welcome premium increases, he stressed that they are necessary to keep pace with the rising cost of healthcare treatment.

Mr Fitzgibbon commented: "We've worked hard to keep our price changes to a record low while still allowing us to fund medical treatment for our members when and where they need it. We're also investing more in our members' future health by leveraging data science and technology to deliver more personalised healthcare through unique products, digital health services and health management programs."

The Managing Director also highlighted that the company's average premiums are still lower than average. Following the 2022 premium increase, NIB's annual average premium per single equivalent unit is estimated to be $2,484. This compares to the industry average of $2,657.

Incidentally, this morning Medibank Private Ltd (ASX: MPL) one-upped NIB by announcing that it will defer its premium increases for five months from 1 April. After which, its premiums will increase by an average of 3.1%, which is its lowest increase in 21 years.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

What does a takeover in the US tell us about the value of Telix shares?

Currently there seems to be a steep discount on this stock.

Read more »

A woman sleeps peacefully in bed with a smile on her face as though she is very satisfied about something.
Healthcare Shares

The global obesity drug boom could be bigger than investors realise for this ASX stock

ResMed shares are down in 2026 on GLP-1 fears.

Read more »

A man has a surprised and relieved expression on his face.
Healthcare Shares

Bell Potter says this ASX 300 share could rise 80%+

The broker believes an impending announcement could put a rocket under this share if it is positive.

Read more »

Medical ASX share price fall represented by worried looking patient awaiting vaccine injection.
Opinions

Under $100, are CSL shares finally too cheap to ignore?

CSL shares are back below $100 after a brutal sell-off.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

Here are the latest growth forecasts for the CSL share price

Can this giant produce healthy returns or is there more downside to come?

Read more »

a nurse wearing a medical mask prepares a patient for a blood donation in a surgical setting.
Healthcare Shares

What is Morgan's updated view on this red hot ASX healthcare stock?

This company released some exciting results.

Read more »

Falling pills in a blue background.
Healthcare Shares

This ASX healthcare company's profit has rocketed 24%

Expansion into new markets is paying off.

Read more »

Doctor checking patient's spine x-ray image.
Healthcare Shares

Are these rocketing ASX healthcare shares a must buy?

These companies all rose significantly to start the week.

Read more »